AD Anti-Chafing
NDC 65197-408, AD Anti-Chafing, ointment, from WellSpring Pharmaceutical Corporation.
- Product NDC
- 65197-408
- Status
- Listed
- Labeler
- WellSpring Pharmaceutical Corporation
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65197-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANOLIN15.5 g/100g
- PETROLATUM53.4 g/100g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65197-408-15 | 65197040815 | 1 TUBE in 1 BOX (65197-408-15) / 42.5 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 65197-408 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65197-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65197-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.